乳酸盐在铁灭调节中的作用:关于瘤进展和治疗的新视角
Nan Wu1, Xiaoqi Wei1, Shuang Yu1
1Department of Central Laboratory, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, PR China.
Pharmacological research
|June 29, 2025
概括
乳酸盐是糖解的副产物,可以差异调节铁. 它在正常条件下促进细胞死亡,但在瘤中赋予抵抗力,推动癌症的进展和治疗挑战.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 铁亡是由代谢调节的依赖铁的细胞死亡.
- 乳酸盐是糖解的副产物,影响能量,脂质代谢和氧化还原平衡.
- 乳酸在铁亡中的作用在正常微环境和瘤微环境之间有所不同.
研究的目的:
- 系统地审查乳酸在铁亡调节中的作用和机制.
- 探索乳酸对瘤进展,转移和耐药性的影响.
- 突出针对癌症治疗的乳酸代谢治疗策略.
主要方法:
- 对乳酸盐,铁亡和癌症代谢研究的文献综述.
- 分析分子机制,包括乳化,脂质过氧化和铁代谢.
- 检查涉及纳米材料和代谢抑制剂的治疗方法.
主要成果:
- 乳酸盐在非瘤环境中促进铁亡.
- 在瘤中,乳酸盐诱导对铁亡的抵抗,促进扩散和转移.
- 机制包括多不和脂肪酸代谢,抗氧化系统,铁和线粒体.
- 乳酸诱导的乳糖化是一个关键的调节途径.
结论:
- 乳酸在铁灭中具有双重作用,取决于上下文.
- 向乳酸代谢为癌症治疗提供了一个有希望的策略.
- 了解乳酸调节的铁亡提供了对瘤进展的新见解.
相关概念视频
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K


